Psyched Wellness announces the largest extraction and shipment of its flagship nootropic (AME-1) to Asia.
Psychedelics
Mydecine Expands Portfolio of Novel Molecules Filing New Patent for MDMA-like Compounds
Mydecine files a new patent application in support of its MDMA-based psychedelic drug research.
Small Pharma Establishes Psychedelic-assisted Therapy Training Program
Small Pharma is starting its DMT-based training program for psychedelic-assisted therapy with its Phase IIa clinical trial due to start immediately.
Novamind Has Applied to Have its Common Shares Posted for Trading on the OTCQB in the United States
Novamind seeks to increase access for U.S. investors through its OTC application.
The Other Magic Mushroom: Why a Canadian Startup Is Suddenly Interested in the Fungus From Super Mario
Psyched Wellness wants to bring the Amanita muscaria fungus to the masses.
The Mental Health Crisis Now Dwarfs Covid-19
The Mental Health Crisis is not only a much larger pandemic than the Covid-19 pandemic. It is also much deadlier.
Psilocybin induces rapid and persistent growth of neural connections in the brain’s frontal cortex, study finds
Yale scientists have found that a single dose of psilocybin given to mice induces a rapid and long-lasting increase in connections between pyramidal neurons in the medial frontal cortex, an area of the brain known to be involved in control and decision-making.
Field Trip Health Ltd. Reports Fiscal First Quarter 2022 Financial Results
Field Trip Health Ltd., a leader in the development and delivery of psychedelic therapies, reported its fiscal first quarter 2022 results for the three months ended June 30, 2021.
The Mental Health Crisis Is Also A Suicide Epidemic
Every 10 minutes, someone in the United States commits suicide -- a suicide epidemic. Psychedelic drugs have the known potential to address and reverse this epidemic.
California Activists File Psilocybin Legalization Ballot Measure As Legislature Advances Broader Psychedelics Bill
California psychoactive compound activists are embarking on a bold journey, filing a petition for the 2022 ballot to make the state the first in the nation to legalize psilocybin mushrooms for any use.
Post-COVID Investment Mega-Opportunity: Mental Health and Psychedelic Drug Stocks
As COVID-19 recedes, a much larger pandemic has been exposed -- the Mental Health Pandemic. A huge crisis; an enormous opportunity.
Psytech To Merge With Wesana; Mycotopia Shareholders Will Benefit From The Transactions
Psytech Inc is becoming a wholly-owned subsidiary of Wesana Health for an acquisition price of CAD$21 million in an all-share transaction.
Red Light Holland Sells Approximately 350,000 Grams of Magic Truffles and Increases Points of Sale for iMicrodose Packs to Six More Smart Shops
Red Light Holland announces that its iMicrodose Packs are now available in 30 storefronts and announces total sales of 350,000 grams of "magic truffles".
Cybin Files its 13th Patent Application and Announces Digital Therapeutics Strategy
Cybin's latest patent application is in support of its proprietary digital therapeutics platform for mental health treatment.
Microdoses of psilocybin and ketamine enhance motivation and attention in rodent models relevant to depression
Low doses of psilocybin and ketamine can heighten food-related motivation and improve attention in poorly-performing male rats, according to new research published in Frontiers in Pharmacology.